MEDNAX 2014 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, January 29, 2015
21 Janvier 2015 - 1:00PM
Business Wire
MEDNAX, Inc. (NYSE: MD), will host an investor conference call
and webcast on Thursday, January 29, 2015 at 10:00 a.m. EST, to
discuss results from operations for the quarter and the twelve
months ended December 31, 2014. A detailed press release will be
issued the morning of January 29, 2015 before the securities
markets open.
The investor conference call will be webcast and may be accessed
at MEDNAX’s website, www.mednax.com/investors.
ABOUT MEDNAX
MEDNAX, Inc. is a national medical group comprised of the
nation's leading providers of neonatal, anesthesia, maternal-fetal
and pediatric physician subspecialty services. Physicians and
advanced practitioners practicing as part of MEDNAX are reshaping
the delivery of care within their specialties and subspecialties,
using evidence-based tools, continuous quality initiatives and
clinical research to enhance patient outcomes and provide
high-quality, cost-effective care. Pediatrix Medical Group, a unit
of MEDNAX, was founded in 1979 and now includes neonatal physicians
who provide services at more than 360 neonatal intensive care
units, who collaborate with affiliated maternal-fetal medicine,
pediatric cardiology and pediatric critical care physician
subspecialists to provide a clinical care continuum. Pediatrix is
also the nation's largest provider of newborn hearing screens.
American Anesthesiology, a division of MEDNAX, was established in
2007 and includes more than 2,350 anesthesiologists and advanced
practitioners who provide anesthesia care to patients in connection
with surgical and other procedures as well as pain management.
MEDNAX, through its affiliated professional corporations, employs
more than 2,625 physicians in 34 states and Puerto Rico. Additional
information is available at www.mednax.com.
Certain statements and information in this press release may be
deemed to contain forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995, Section 27A
of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. Forward-looking
statements may include, but are not limited to, statements relating
to our objectives, plans and strategies, and all statements, other
than statements of historical facts, that address activities,
events or developments that we intend, expect, project, believe or
anticipate will or may occur in the future. These statements are
often characterized by terminology such as “believe”, “hope”,
“may”, “anticipate”, “should”, “intend”, “plan”, “will”, “expect”,
“estimate”, “project”, “positioned”, “strategy” and similar
expressions, and are based on assumptions and assessments made by
MEDNAX’s management in light of their experience and their
perception of historical trends, current conditions, expected
future developments and other factors they believe to be
appropriate. Any forward-looking statements in this press release
are made as of the date hereof, and MEDNAX undertakes no duty to
update or revise any such statements, whether as a result of new
information, future events or otherwise. Forward-looking statements
are not guarantees of future performance and are subject to risks
and uncertainties. Important factors that could cause actual
results, developments, and business decisions to differ materially
from forward-looking statements are described in MEDNAX’s most
recent Annual Report on Form 10-K and its Quarterly Reports on Form
10-Q, including the sections entitled “Risk Factors”, as well
MEDNAX’s current reports on Form 8-K, filed with the Securities and
Exchange Commission.
MEDNAX, Inc.Charles Lynch, 954-384-0175, x 5692Vice President,
Strategy and Investor Relationscharles_lynch@mednax.com
MacDonald, Dettwiler & (NYSE:MDA)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
MacDonald, Dettwiler & (NYSE:MDA)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024